RecruitingPhase 4NCT06374758
Accelerated ART Initiation for PWHIV Who Are Out of Care
Studying Lethal ataxia with deafness and optic atrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Missouri-Columbia
- Principal Investigator
- Dima Dandachi, MD, MPHUniversity of Missouri-Columbia
- Intervention
- The Accelerate model of care(other)
- Enrollment
- 120 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2026
Study locations (4)
- University of Missouri-Columbia, Columbia, Missouri, United States
- KC Care Health Center, Kansas City, Missouri, United States
- AIDS Project of the Ozarks, Springfield, Missouri, United States
- NOVUS Health, St Louis, Missouri, United States
Collaborators
Gilead Sciences
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06374758 on ClinicalTrials.govOther trials for Lethal ataxia with deafness and optic atrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05912270Orchestra in Class, a Novel Booster for Executive Functions and Brain Development in Young Primary School ChildrenSchool of Health Sciences Geneva
- ACTIVE NOT RECRUITINGNANCT06176859Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) StudyMassachusetts General Hospital
See all trials for Lethal ataxia with deafness and optic atrophy →